We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Scanning Platform Provides Management and Analysis of Digital Pathology Images

By LabMedica International staff writers
Posted on 25 Jul 2012
A scanning platform processes batches of slides using both brightfield and multichannel fluorescence providing a solution for digital pathology scanning.

The platform offers monochrome detectors for fluorescence, which provide excellent separation of individual fluorophores that may be close in wavelength, while color detectors for brightfield provide excellent digital slide capture quality.

The SCN400 2.2 by Leica Microsystems (Wetzlar, Germany) can handle up to five fluorescence channels per slide, providing a truly flexible whole slide scanning solution.

Multiple markers are captured on a single sample, with clear focus and channel separation, ensuring that scientists maximize results from precious or rare samples. More...
Capacity for multiple filter cubes enables up to seven distinct fluorescence channels to be utilized across a scanning batch, providing flexibility for the varied samples in various laboratories.

The advanced tissue finding system automatically identifies areas for capture for brightfield imaging. Leica’s Dynamic Focus saves the overhead cost of slide premapping, rapidly scanning high quality whole slide images. The addition of the SL801 autoloader with capacity for 384 slides makes the SCN400 2.2 a fully automated, high-throughput system.

Dr. Donal O’Shea, head of digital pathology at Leica Microsystems, said that the advanced brightfield and fluorescence imaging capacity provides an optimal single-platform scanner for the varied samples used by biomarker discovery and translational scientists.

Related Links:

Leica Microsystems




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.